Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aoyama

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Die Pharmazie|March 1, 2013
Biochemical and hematologic effects of polyvinylpyrrolidone-wrapped fullerene C60 after oral administrationK Yamashita, Y Yoshioka, H Pan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in ratsY Yamamura, S Nakamura, S Itoh, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 16, 2006
Spectroscopic characterization of an ultrashort-pulse-laser-driven Ar cluster target incorporating both Boltzmann and particle-in-cell modelsM E Sherrill, J Abdallah, G Csanak, et al.
British Journal of Pharmacology|April 26, 2000
Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypesS Nakamura, Y Yamamura, S Itoh, et al.
The Science of the Total Environment|November 24, 1999
Anthropogenic radionuclides in seawater of the Far Eastern SeasY Ikeuchi, H Amano, M Aoyama, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Die Pharmazie|March 1, 2013
Biochemical and hematologic effects of polyvinylpyrrolidone-wrapped fullerene C60 after oral administrationK Yamashita, Y Yoshioka, H Pan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in ratsY Yamamura, S Nakamura, S Itoh, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 16, 2006
Spectroscopic characterization of an ultrashort-pulse-laser-driven Ar cluster target incorporating both Boltzmann and particle-in-cell modelsM E Sherrill, J Abdallah, G Csanak, et al.
British Journal of Pharmacology|April 26, 2000
Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypesS Nakamura, Y Yamamura, S Itoh, et al.
The Science of the Total Environment|November 24, 1999
Anthropogenic radionuclides in seawater of the Far Eastern SeasY Ikeuchi, H Amano, M Aoyama, et al.
Pageof 13